GNOM ETF

$44.70

Returns Overview

1 Month
-1.72%
3 Months
+1.16%
6 Months
+27.89%
YTD
+2.64%
1 Year
+27.30%
3 Years
-2.27%
5 Years
-13.17%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would GNOM have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

-1.72%

3 Months Performance

+1.16%

6 Months Performance

+27.89%

1 Year Performance

+27.30%

Benchmark & Peers

Benchmark
Solactive Genomics Index(^SOLAGI)
This ETF (YTD)
+2.64%
Peer Avg (YTD)
+1.55%
vs Peers
+1.10%

GNOM ETF Performance

GNOM performance across multiple time periods: 1-month -1.72%, YTD 2.64%, 1-year 27.30%, 3-year -2.27%, 5-year -13.17%.

GNOM returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.50%, investors should weigh costs against performance when evaluating this ETF.

GNOM performance comparison shows side-by-side returns with another fund. GNOM alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-1.72%N/A
3 Months+1.16%N/A
6 Months+27.89%N/A
1 Year+27.30%N/A
3 Years-2.27%N/A
5 Years-13.17%N/A

All returns shown are total returns, not annualized